​ASCO-GU 2017: POSTERS – A166


February 25, 2017

  • Share this post:

A selection of posters from the 2017 Genitourinary Cancers Symposium is highlighted in a series of interviews.

Speaker: Esther Bouman-Wammes

Poster: A166 - A randomized phase II trial of docetaxel plus carboplatin versus docetaxel in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial

This program is financially supported by Bayer and Janssen Oncology.

Related articles